Febuxostat (INN; trade names: Adenuric in Europe and New Zealand Febutaz in India and Takeda’s Uloric in the US) is a urate lowering drug an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and chronic gout.Febuxostat received marketing approval by the European Medicines Agency on April 21 2008 and was approved by the U.S.
This page contains content from the copyrighted Wikipedia article "Febuxostat"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
